{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:06:06Z","timestamp":1789185966480,"version":"build-2803163510"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"DOI":"10.1007\/s11427-026-3455-4","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:09:18Z","timestamp":1789182558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The hidden reservoir of INSTI resistance: large scale sequence analysis identifies prevalent Gag NC mutations compromising dolutegravir and cabotegravir efficacy"],"prefix":"10.1007","author":[{"given":"Defu","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"3455_CR1","first-page":"3","volume":"33","author":"Conference on Retroviruses and Opportunistic Infections","year":"2025","unstructured":"Conference on Retroviruses and Opportunistic Infections. (2025). Abstracts from the 2025 conference on retroviruses and opportunistic infections. Top Antivir Med 33, 3\u2013454.","journal-title":"Top Antivir Med"},{"key":"3455_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12879-023-08288-8","volume":"23","author":"RS Diaz","year":"2023","unstructured":"Diaz, R.S., Hunter, J.R., Camargo, M., Dias, D., Galinskas, J., Nassar, I., de Lima, I.B., Caldeira, D. B., Sucupira, M.C., and Schechter, M. (2023). Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil. BMC Infect Dis 23, 347.","journal-title":"BMC Infect Dis"},{"key":"3455_CR3","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/hiv.70065","volume":"26","author":"J Ghosn","year":"2025","unstructured":"Ghosn, J., Chow, J., Gandhi, M., G\u00f3rgolas, M., Al-Hayani, A., Tookes, H., Lee, M., Kaiser, E.F., Malebranche, D., Bognar, F.A., et al. (2025). Rapid start with bictegravir\/emtricitabine\/tenofovir alafenamide (B\/F\/TAF) as initial treatment in people with human immunodeficiency virus-1 (HIV-1): a systematic literature review of clinical and patient-reported outcomes. HIV Med 26, 1375\u20131394.","journal-title":"HIV Med"},{"key":"3455_CR4","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.3390\/v15122426","volume":"15","author":"C Henegar","year":"2023","unstructured":"Henegar, C., Letang, E., Wang, R., Hicks, C., Fox, D., Jones, B., de Ruiter, A., and Vannappagari, V. (2023). A comprehensive literature review of treatment-emergent integrase resistance with dolutegravir-based regimens in real-world settings. Viruses 15, 2426.","journal-title":"Viruses"},{"key":"3455_CR5","doi-asserted-by":"publisher","first-page":"eadz8980","DOI":"10.1126\/sciadv.adz8980","volume":"11","author":"Y Hikichi","year":"2025","unstructured":"Hikichi, Y., Burdick, R.C., Patro, S.C., Ding, S.Y., Luke, B.T., Clark, E.D., Ablan, S.D., Wu, X., Pathak, V.K., and Freed, E.O. (2025). Elucidating the mechanism by which HIV-1 nucleocapsid mutations confer resistance to integrase strand transfer inhibitors. Sci Adv 11, eadz8980.","journal-title":"Sci Adv"},{"key":"3455_CR6","doi-asserted-by":"publisher","first-page":"107294","DOI":"10.1016\/j.ijantimicag.2024.107294","volume":"64","author":"S Liu","year":"2024","unstructured":"Liu, S., Yuan, D., Zhou, Y., Wang, B., and Hu, H. (2024). Beware of resistance to 2nd-generation integrase inhibitors: a systematic meta-analysis of HIV-1 integrase inhibitors resistance and drug resistance mutations. Int J Antimicrob Agents 64, 107294.","journal-title":"Int J Antimicrob Agents"},{"key":"3455_CR7","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1093\/jac\/dkz256","volume":"74","author":"SY Rhee","year":"2019","unstructured":"Rhee, S.Y., Grant, P.M., Tzou, P.L., Barrow, G., Harrigan, P.R., Ioannidis, J.P.A., and Shafer, R.W. (2019). A systematic review of the genetic mechanisms of dolutegravir resistance. J Antimicrob Chemother 74, 3135\u20133149.","journal-title":"J Antimicrob Chemother"},{"key":"3455_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/infdis\/jiy176","volume":"218","author":"IEA Wijting","year":"2018","unstructured":"Wijting, I.E.A., Lungu, C., Rijnders, B.J.A., van der Ende, M.E., Pham, H.T., Mesplede, T., Pas, S.D., Voermans, J.J.C., Schuurman, R., van de Vijver, D.A. M.C., et al. (2018). HIV-1 resistance dynamics in patients with virologic failure to dolutegravir maintenance monotherapy. J Infect Dis 218, 688\u2013697.","journal-title":"J Infect Dis"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-026-3455-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-026-3455-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-026-3455-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:09:22Z","timestamp":1789182562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-026-3455-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":8,"alternative-id":["3455"],"URL":"https:\/\/doi.org\/10.1007\/s11427-026-3455-4","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}